Here are what the editors at HealthDay consider to be the most important developments in Rheumatology for October 2015. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Synchronized Prescription Renewal Process Saves Time
FRIDAY, Oct. 30, 2015 (HealthDay News) — A synchronized prescription renewal process can save physicians time and money, which can be dedicated to patient care, according to a report from the American Medical Association (AMA).
Increasing Numbers of Med School Applicants, Enrollees
FRIDAY, Oct. 30, 2015 (HealthDay News) — There has been a 25 percent increase in the number of medical school enrollees since 2002, with the number reaching an all-time high of 20,630 this year, according to a report published online Oct. 22 by the Association of American Medical Colleges (AAMC).
Some RA Treatments Up Second Nonmelanoma Skin Cancer Risk
THURSDAY, Oct. 29, 2015 (HealthDay News) — For patients with rheumatoid arthritis (RA) and inflammatory bowel disease (IBD) with prior nonmelanoma skin cancer (NMSC), the risk of second NMSC varies with different treatments, according to a study published online Oct. 28 in JAMA Dermatology.
Lidocaine, Hyaluronidase Mix Works Faster in Myofascial Pain
THURSDAY, Oct. 29, 2015 (HealthDay News) — In patients with myofascial pain syndrome (MPS), trigger point injection (TPI) with lidocaine and hyaluronidase works more quickly on the first day following injection than lidocaine alone, but there are no significant differences between the methods after four days, according to a study published online Oct. 7 in Pain Practice.
Nearly 15 Percent of Plans Lack In-Network Specialists
WEDNESDAY, Oct. 28, 2015 (HealthDay News) — A considerable proportion of federal marketplace plans lack at least one in-network specialist, according to a research letter published in the Oct. 27 issue of the Journal of the American Medical Association.
Full Text (subscription or payment may be required)
Physician Emphasizes Importance of Saying Thank You
TUESDAY, Oct. 27, 2015 (HealthDay News) — The importance of thanking patients for coming to see you, the physician, is described in an essay published online in Medical Economics.
Full Text
Vitamin D Supplementation Beneficial in Rheumatoid Arthritis
TUESDAY, Oct. 27, 2015 (HealthDay News) — For patients with active rheumatoid arthritis and vitamin D deficiency, vitamin D supplementation is associated with improved disease activity within a short period, according to a study published online Oct. 20 in the International Journal of Rheumatic Diseases.
AMA: Eight Reasons for Nonadherence to Medications
FRIDAY, Oct. 23, 2015 (HealthDay News) — Eight reasons associated with patient’s intentional nonadherence to medications have been identified in a report published by the American Medical Association (AMA).
Pain Relief, Function Up Post Knee Replacement in Arthritis
THURSDAY, Oct. 22, 2015 (HealthDay News) — Total knee replacement usually results in greater pain relief and better joint function after a year than nonsurgical osteoarthritis treatment, researchers report in the Oct. 22 issue of the New England Journal of Medicine.
Outpatient Spending Higher With Physician-Hospital Integration
TUESDAY, Oct. 20, 2015 (HealthDay News) — Markets with greater increases in physician-hospital integration show greater increases in spending for outpatient care, but not inpatient care, for a large commercially insured population, according to a study published online Oct. 19 in JAMA Internal Medicine.
Opioid Prescriptions Common With Fibromyalgia
TUESDAY, Oct. 20, 2015 (HealthDay News) — Opioid use is widespread among patients with newly diagnosed fibromyalgia, and patients taking opioids have a decreased likelihood of receiving guideline-recommended medications, according to a study published online Oct. 7 in Pain Practice.
Americans Spend More on Health Care, but Fare Worse
MONDAY, Oct. 12, 2015 (HealthDay News) — When compared to 12 other industrialized nations, Americans spend more on health care services, but they fare worst in terms of life expectancy, according to recent findings from The Commonwealth Fund.
Guidelines Developed for Managing Conflicts of Interest
TUESDAY, Oct. 6, 2015 (HealthDay News) — The Guidelines International Network has developed principles for disclosure and management of conflicts of interest (COIs) during the clinical practice guideline development process, according to a report published in the Oct. 6 issue of the Annals of Internal Medicine.
Full Text (subscription or payment may be required)
Modified SOAP Ups Student Awareness of Health Care Costs
MONDAY, Oct. 5, 2015 (HealthDay News) — Modification of the traditional Subjective-Objective-Assessment-Plan (SOAP) presentation to consider value (SOAP-V) can help medical students learn to practice high-value, cost-conscious care, according to a study published online Sept. 28 in the Journal of Hospital Medicine.
Providers Must Understand Legal Limits of Telemedicine
FRIDAY, Oct. 2, 2015 (HealthDay News) — In order to minimize risk when practicing telemedicine, providers should ensure they hold the proper medical licenses, have medical liability insurance coverage, and communicate with patients regarding the potential risks of telemedicine, according to a report published in Medical Economics.
Serotonin Levels Low in Ankylosing Spondylitis
FRIDAY, Oct. 2, 2015 (HealthDay News) — Patients with ankylosing spondylitis (AS) have lower serotonin levels than healthy controls and patients with rheumatoid arthritis (RA), according to a study published online Sept. 30 in the Journal of Bone and Mineral Research.
Strategies Provided for Improving EHR Efficiency
THURSDAY, Oct. 1, 2015 (HealthDay News) — Several strategies can be implemented in order to better use electronic health records (EHRs) for patient care and efficiency, according to an article published in Medical Economics.
Two Experimental Drugs Promising for Psoriasis Rx
THURSDAY, Oct. 1, 2015 (HealthDay News) — Two experimental drugs, brodalumab and secukinumab, show promise in treating psoriasis and psoriatic arthritis, according to two studies published in the Oct. 1 issue of the New England Journal of Medicine.
Full Text 1 (subscription or payment may be required)
Full Text 2 (subscription or payment may be required)
Copyright © 2015 ScoutNews, LLC. All rights reserved.
